News

Scientists have developed a microfluidic organ-on-a-chip preclinical model of the cystic fibrosis lung airway.

Riluzole, a drug approved to treat amyotrophic lateral sclerosis, could slow the loss of a particular brain cell that occurs in Niemann-Pick disease type C, a rare genetic disorder affecting children and adolescents, suggests a study in mice.

A plant-based antiviral treatment for COVID-19 has been shown to be effective at treating all variants of SARS-CoV-2, even the highly infectious Delta variant.

The current standard for women receiving the human papillomavirus (HPV) vaccine is a three-dose regimen, however, a randomized controlled trial of 2,275 women in Kenya has shown that a single dose was highly effective.

Researchers have found that variants of the venom produced by the cone snail could offer future possibilities for developing new fast-acting drugs to help treat diabetes.

New research points to a well-known and widely available drug for alcoholism as a possible treatment for COVID-19.

Researchers have developed a novel and sustainable way to create pharmaceuticals using blue light.

Researchers have created a computational operation and embedded it into a protein. In doing so, they are now able to rapidly activate the protein using light and the drug rapamycin. When activated, the cells underwent internal changes that enhanced their adhesive capabilities, which ultimately decreased their motility.

Researchers revealed a striking pattern following a functional screen of extracts from plants collected in Muir Woods National Monument, in coastal redwood forest land in California. They found plants with a long history of use by Native Americans as topical analgesics, were often also used as gastrointestinal aids.

Researchers have developed a 3D cell culturing platform that allows the study of lung fibroblasts and their microenvironment. The platform enables measurement of cell behaviors and changes involved in the progression of idiopathic pulmonary fibrosis.